The government is poised to implement supply control of Peramiflu inj., an injection for transfusion, following the management of oral influenza treatment, Tamiflu.

Peramiflu inj. is experiencing out-of-stock in medical services due to a recent increase in demand.

Health Insurance Review and Assessment Service (HIRA)’s Korea Pharmaceutical Information Service (KPIS) designated two types of Green Cross’s Peramiflu Inj. (peramivir), after receiving reports through the information channel, as drug shortages, and plans to provide inventory information on these drugs.

The information service has been operating a channel for receiving reports on drug shortages since Ju